Singapore - English - HSA (Health Sciences Authority)

johnson & johnson international (singapore) pte ltd - guselkumab - injection, solution - guselkumab 100mg/ml

United Kingdom - English - myHealthbox

janssen-cilag ltd - risperidone - tablets - 4 mg - other antipsychotic - it is indicated for the treatment of schizophrenia; for the treatment of moderate to severe manic episodes associated with bipolar disorders; in patients with moderate to severe alzheimer's dementia; forf persistent aggression in conduct disorder in children from the age of 5 years and adolescents with subaverage intellectual functioning or mental retardation

United Kingdom - English - myHealthbox

janssen-cilag ltd - risperidone - tablets - 3 mg - other antipsychotic - it al is used to treat the following: schizophrenia, mania, aggression in people with alzheimer’s dementia, aggression in intellectually disabled children (at least 5 years of age) and adolescents with conduct disorder.

Malta - English - Medicines Authority

janssen-cilag international nv turnhoutsewes 30, b-2340 beerse, belgium - domperidone - suppository - domperidone 30 mg - drugs for functional gastrointestinal disorders

New Zealand - English - Medsafe (Medicines Safety Authority)

janssen-cilag (new zealand) ltd - miglustat 100mg - capsule - 100 mg - active: miglustat 100mg excipient: gelatin magnesium stearate povidone sodium starch glycolate titanium dioxide - zavesca® is indicated for the treatment of progressive neurological manifestations in adult and paediatric patients with niemann-pick type c disease.

European Union - English - EMA (European Medicines Agency)

janssen-cilag international nv - fentanyl hydrochloride - pain, postoperative - analgesics - management of acute moderate to severe post-operative pain for use in a hospital setting only

European Union - English - EMA (European Medicines Agency)

janssen-cilag international nv - becaplermin - wound healing; skin ulcer - preparations for treatment of wounds and ulcers - regranex is indicated, in association with other good wound care measures, to promote granulation and thereby the healing of full-thickness, neuropathic, chronic, diabetic ulcers less than or equal to 5 cm2.

New Zealand - English - Medsafe (Medicines Safety Authority)

janssen-cilag (new zealand) ltd - bendamustine hydrochloride 100mg equivalent to bendamustine 90.8 mg - powder for infusion - 100 mg - active: bendamustine hydrochloride 100mg equivalent to bendamustine 90.8 mg excipient: mannitol - first line treatment of chronic lymphocytic leukaemia (binet stage b or c).

New Zealand - English - Medsafe (Medicines Safety Authority)

janssen-cilag (new zealand) ltd - bendamustine hydrochloride 25mg equivalent to bendamustine 22.7 mg - powder for infusion - 25 mg - active: bendamustine hydrochloride 25mg equivalent to bendamustine 22.7 mg excipient: mannitol - first line treatment of chronic lymphocytic leukaemia (binet stage b or c).

Australia - English - Department of Health (Therapeutic Goods Administration)

janssen-cilag pty ltd - ustekinumab, quantity: 135 mg - injection, solution - excipient ingredients: histidine hydrochloride monohydrate; sucrose; polysorbate 80; methionine; disodium edetate; water for injections; histidine - crohn?s disease,stelara is indicated for the treatment of adult patients with moderately to severely active crohn?s disease who have had an inadequate response, lost response, or were intolerant to either conventional therapy or a tnf alpha antagonist or have medical contraindications to such therapies.,ulcerative colitis,stelara is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis.